BCMT was founded in 2009 and is based in Houston, with a primary focus on investments in the United States. The firm specializes in biotechnology and developer platform fields, and typically invests in startups that are 4-5 years old. BCMT's investment strategy involves thorough diligence and a deep understanding of the underlying science to maximize returns. They provide seed capital for proof-of-concept research and play a significant role in the structuring and development of the start-up company. BCMT prefers to lead seed and first rounds and continues to co-invest in later rounds.